Overcoming paclitaxel resistance in uterine endometrial cancer using a COX-2 inhibitor.

Hasegawa, Kiyoshi; Ishikawa, Kunimi; Kawai, Satoshi; Torii, Yutaka; Kawamura, Kyoko; Kato, Rina; Tsukada, Kazuhiko; Udagawa, Yasuhiro

Hasegawa, Kiyoshi; Ishikawa, Kunimi; Kawai, Satoshi; Torii, Yutaka; Kawamura, Kyoko; Kato, Rina; Tsukada, Kazuhiko; Udagawa, Yasuhiro.

Affiliation

Hasegawa K; Department of Obstetrics and Gynecology, Fujita Health University, Banbuntane Hotokukai Hospital, Nagoya, Aichi 4548509, Japan.

Oncol Rep ; 30(6): 2937-44, 2013 Dec.

Article in En | MEDLINE | ID: mdl-24100466

Subject(s)

Cyclooxygenase 2/genetics; Drug Resistance, Neoplasm/genetics; Endometrial Neoplasms/drug therapy; Etodolac/administration & dosage; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1/biosynthesis; ATP Binding Cassette Transporter, Subfamily B, Member 1/genetics; Cell Line, Tumor; Cyclooxygenase 2 Inhibitors/administration & dosage; Endometrial Neoplasms/enzymology; Endometrial Neoplasms/pathology; Female; Gene Expression Regulation, Neoplastic/drug effects; Humans; Paclitaxel/administration & dosage; RNA, Messenger/biosynthesis; RNA, Messenger/genetics

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Endometrial Neoplasms / Etodolac / Drug Resistance, Neoplasm / Cyclooxygenase 2 Limits: Female / Humans Language: En Journal: Oncol Rep Journal subject: NEOPLASIAS Year: 2013 Document type: Article Affiliation country: Japan

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google